Cargando…

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders

This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD). Prevalence and correlates of NPS knowledge and use were assessed in 18...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Farra, Deborah, Valdesalici, Alice, Zecchinato, Giancarlo, De Sandre, Alfio, Saccon, Diego, Simonato, Pierluigi, Corazza, Ornella, Martinotti, Giovanni, Smith, Andrew L., Solmi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776073/
https://www.ncbi.nlm.nih.gov/pubmed/35055743
http://dx.doi.org/10.3390/ijerph19020915
_version_ 1784636742632996864
author Dal Farra, Deborah
Valdesalici, Alice
Zecchinato, Giancarlo
De Sandre, Alfio
Saccon, Diego
Simonato, Pierluigi
Corazza, Ornella
Martinotti, Giovanni
Smith, Andrew L.
Solmi, Marco
author_facet Dal Farra, Deborah
Valdesalici, Alice
Zecchinato, Giancarlo
De Sandre, Alfio
Saccon, Diego
Simonato, Pierluigi
Corazza, Ornella
Martinotti, Giovanni
Smith, Andrew L.
Solmi, Marco
author_sort Dal Farra, Deborah
collection PubMed
description This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD). Prevalence and correlates of NPS knowledge and use were assessed in 185 patients with SUD in three addiction services (Padova, Belluno, Feltre) in the Veneto region with an ad-hoc designed survey. Two thirds of the samples reported knowing NPS and one third reported using them. NPS were considered by them less dangerous than “regular” substances of abuse (t = 6.06 mean 0.78, p < 0.001). Factors associated with NPS use were youth (OR = 4.81; p < 0.001), studentship (OR = 4.99; p = 0.004), subsequent mental disorders diagnosis (OR = 2.49; p = 0.027), suicide attempt history (OR = 11.67; p < 0.001), home detention (OR = 2.30; p = 0.040), residential care (OR = 5.66; p = 0.002), and polysubstance abuse (t = 8.99 mean 2.65 p < 0.001). NPS use in patients with SUD is highly prevalent, particularly in the youngest age group, and associated with psychiatric comorbidity and worse prognosis. It is crucial to systematically assess NPS use and inform addiction service users with SUD of the toxic and potentially lethal side effects. Mental healthcare professionals working in addiction services should receive education and training. Cohort and longitudinal studies are needed.
format Online
Article
Text
id pubmed-8776073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87760732022-01-21 Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders Dal Farra, Deborah Valdesalici, Alice Zecchinato, Giancarlo De Sandre, Alfio Saccon, Diego Simonato, Pierluigi Corazza, Ornella Martinotti, Giovanni Smith, Andrew L. Solmi, Marco Int J Environ Res Public Health Article This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD). Prevalence and correlates of NPS knowledge and use were assessed in 185 patients with SUD in three addiction services (Padova, Belluno, Feltre) in the Veneto region with an ad-hoc designed survey. Two thirds of the samples reported knowing NPS and one third reported using them. NPS were considered by them less dangerous than “regular” substances of abuse (t = 6.06 mean 0.78, p < 0.001). Factors associated with NPS use were youth (OR = 4.81; p < 0.001), studentship (OR = 4.99; p = 0.004), subsequent mental disorders diagnosis (OR = 2.49; p = 0.027), suicide attempt history (OR = 11.67; p < 0.001), home detention (OR = 2.30; p = 0.040), residential care (OR = 5.66; p = 0.002), and polysubstance abuse (t = 8.99 mean 2.65 p < 0.001). NPS use in patients with SUD is highly prevalent, particularly in the youngest age group, and associated with psychiatric comorbidity and worse prognosis. It is crucial to systematically assess NPS use and inform addiction service users with SUD of the toxic and potentially lethal side effects. Mental healthcare professionals working in addiction services should receive education and training. Cohort and longitudinal studies are needed. MDPI 2022-01-14 /pmc/articles/PMC8776073/ /pubmed/35055743 http://dx.doi.org/10.3390/ijerph19020915 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dal Farra, Deborah
Valdesalici, Alice
Zecchinato, Giancarlo
De Sandre, Alfio
Saccon, Diego
Simonato, Pierluigi
Corazza, Ornella
Martinotti, Giovanni
Smith, Andrew L.
Solmi, Marco
Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title_full Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title_fullStr Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title_full_unstemmed Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title_short Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
title_sort knowledge and use of novel psychoactive substances in an italian sample with substance use disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776073/
https://www.ncbi.nlm.nih.gov/pubmed/35055743
http://dx.doi.org/10.3390/ijerph19020915
work_keys_str_mv AT dalfarradeborah knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT valdesalicialice knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT zecchinatogiancarlo knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT desandrealfio knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT saccondiego knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT simonatopierluigi knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT corazzaornella knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT martinottigiovanni knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT smithandrewl knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders
AT solmimarco knowledgeanduseofnovelpsychoactivesubstancesinanitaliansamplewithsubstanceusedisorders